{"id":6600,"date":"2023-06-30T08:16:31","date_gmt":"2023-06-30T08:16:31","guid":{"rendered":"https:\/\/founderlodge.com\/latest-news\/?p=6600"},"modified":"2023-06-30T08:16:32","modified_gmt":"2023-06-30T08:16:32","slug":"luminopia-secures-16-million-in-series-a-funding-to-advance-breakthrough-neuro-visual-disorder-treatments","status":"publish","type":"post","link":"https:\/\/founderlodge.com\/latest-news\/luminopia-secures-16-million-in-series-a-funding-to-advance-breakthrough-neuro-visual-disorder-treatments\/","title":{"rendered":"Luminopia Secures $16 Million in Series A Funding to Advance Breakthrough Neuro-Visual Disorder Treatments"},"content":{"rendered":"\n<figure class=\"wp-block-image size-full is-resized\"><img decoding=\"async\" src=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/06\/image-342.png\" alt=\"\" class=\"wp-image-6601\" width=\"86\" height=\"86\" srcset=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/06\/image-342.png 200w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/06\/image-342-150x150.png 150w\" sizes=\"(max-width: 86px) 100vw, 86px\" \/><\/figure>\n\n\n\n<p>Cambridge, Massachusetts \u2013 <a href=\"https:\/\/www.luminopia.com\/\">Luminopia<\/a>, a leading biotechnology company, announced today the successful completion of its Series A funding round, raising an impressive $16,000,000. The funding round was led by <a href=\"https:\/\/www.usvp.com\/\">U.S. Venture Partners<\/a> and <a href=\"https:\/\/www.shangbaycapital.com\/\">ShangBay Capital<\/a>, two prominent venture capital firms with a strong track record of supporting innovative healthcare solutions.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"456\" src=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/06\/image-343-1024x456.png\" alt=\"\" class=\"wp-image-6602\" srcset=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/06\/image-343-1024x456.png 1024w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/06\/image-343-300x133.png 300w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/06\/image-343-768x342.png 768w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/06\/image-343.png 1389w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p>Luminopia has emerged as a pioneer in the field, revolutionizing treatments for significant neuro-visual disorders. The company&#8217;s mission is to develop and deliver digital therapeutics that not only undergo rigorous evaluation for FDA approval but also engage patients in a meaningful and enjoyable manner.<\/p>\n\n\n\n<p>As an esteemed Innovation Partner of Boston Children&#8217;s Hospital, Luminopia is dedicated to addressing one of the most prevalent neuro-visual disorders affecting children \u2013 amblyopia, commonly known as lazy eye. Amblyopia is the leading cause of vision loss among children and often requires early intervention to prevent long-term vision impairment. Luminopia&#8217;s cutting-edge lead product aims to transform the treatment landscape for amblyopia and provide children with a brighter future.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"507\" src=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/06\/image-344-1024x507.png\" alt=\"\" class=\"wp-image-6603\" srcset=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/06\/image-344-1024x507.png 1024w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/06\/image-344-300x148.png 300w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/06\/image-344-768x380.png 768w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/06\/image-344.png 1293w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p>&#8220;We are grateful to have the support of U.S. Venture Partners and ShangBay Capital in this significant milestone for Luminopia,&#8221; said <a href=\"https:\/\/www.linkedin.com\/in\/xiaoscott\/\">Scott Xiao<\/a>, Co-Founder of Luminopia. &#8220;This funding will play a pivotal role in advancing our groundbreaking treatments for neuro-visual disorders, with a focus on our lead product targeting amblyopia. Our collaboration with Boston Children&#8217;s Hospital has been invaluable, and we are excited to continue our mission of transforming the lives of children with vision impairments.&#8221;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cambridge, Massachusetts \u2013 Luminopia, a leading biotechnology company, announced today the successful completion of its Series A funding round, raising an impressive $16,000,000. The funding round was led by U.S. Venture Partners and ShangBay Capital, two prominent venture capital firms with a strong track record of supporting innovative healthcare solutions. Luminopia has emerged as a [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":6604,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":""},"categories":[2],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.2.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Luminopia Secures $16 Million in Series A Funding<\/title>\n<meta name=\"description\" content=\"Cambridge, Massachusetts \u2013 Luminopia, a leading biotechnology company, announced today the successful completion of its Series A funding\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/founderlodge.com\/latest-news\/luminopia-secures-16-million-in-series-a-funding-to-advance-breakthrough-neuro-visual-disorder-treatments\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Luminopia Secures $16 Million in Series A Funding\" \/>\n<meta property=\"og:description\" content=\"Cambridge, Massachusetts \u2013 Luminopia, a leading biotechnology company, announced today the successful completion of its Series A funding\" \/>\n<meta property=\"og:url\" content=\"https:\/\/founderlodge.com\/latest-news\/luminopia-secures-16-million-in-series-a-funding-to-advance-breakthrough-neuro-visual-disorder-treatments\/\" \/>\n<meta property=\"og:site_name\" content=\"Founder Lodge Latest News\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-30T08:16:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-30T08:16:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/06\/image-345.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1601\" \/>\n\t<meta property=\"og:image:height\" content=\"782\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"ucheezuma\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ucheezuma\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/luminopia-secures-16-million-in-series-a-funding-to-advance-breakthrough-neuro-visual-disorder-treatments\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/luminopia-secures-16-million-in-series-a-funding-to-advance-breakthrough-neuro-visual-disorder-treatments\/\"},\"author\":{\"name\":\"ucheezuma\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/2854d3c2f2bb3f7ff9ae13c649048af3\"},\"headline\":\"Luminopia Secures $16 Million in Series A Funding to Advance Breakthrough Neuro-Visual Disorder Treatments\",\"datePublished\":\"2023-06-30T08:16:31+00:00\",\"dateModified\":\"2023-06-30T08:16:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/luminopia-secures-16-million-in-series-a-funding-to-advance-breakthrough-neuro-visual-disorder-treatments\/\"},\"wordCount\":251,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\"},\"articleSection\":[\"Daily Startup Funding News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/founderlodge.com\/latest-news\/luminopia-secures-16-million-in-series-a-funding-to-advance-breakthrough-neuro-visual-disorder-treatments\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/luminopia-secures-16-million-in-series-a-funding-to-advance-breakthrough-neuro-visual-disorder-treatments\/\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/luminopia-secures-16-million-in-series-a-funding-to-advance-breakthrough-neuro-visual-disorder-treatments\/\",\"name\":\"Luminopia Secures $16 Million in Series A Funding\",\"isPartOf\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#website\"},\"datePublished\":\"2023-06-30T08:16:31+00:00\",\"dateModified\":\"2023-06-30T08:16:32+00:00\",\"description\":\"Cambridge, Massachusetts \u2013 Luminopia, a leading biotechnology company, announced today the successful completion of its Series A funding\",\"breadcrumb\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/luminopia-secures-16-million-in-series-a-funding-to-advance-breakthrough-neuro-visual-disorder-treatments\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/founderlodge.com\/latest-news\/luminopia-secures-16-million-in-series-a-funding-to-advance-breakthrough-neuro-visual-disorder-treatments\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/luminopia-secures-16-million-in-series-a-funding-to-advance-breakthrough-neuro-visual-disorder-treatments\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/founderlodge.com\/latest-news\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Luminopia Secures $16 Million in Series A Funding to Advance Breakthrough Neuro-Visual Disorder Treatments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#website\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/\",\"name\":\"Founder Lodge Latest News\",\"description\":\"Get the latest updates on funding rounds and investment news for startups and businesses. Stay informed on capital raising trends and who&#039;s raising capital.\",\"publisher\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/founderlodge.com\/latest-news\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\",\"name\":\"Founder Lodge\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Founder Lodge\"},\"image\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/2854d3c2f2bb3f7ff9ae13c649048af3\",\"name\":\"ucheezuma\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ff09ab70d3a1229d484147623818e0af?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ff09ab70d3a1229d484147623818e0af?s=96&d=mm&r=g\",\"caption\":\"ucheezuma\"},\"url\":\"https:\/\/founderlodge.com\/latest-news\/author\/ucheezuma\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Luminopia Secures $16 Million in Series A Funding","description":"Cambridge, Massachusetts \u2013 Luminopia, a leading biotechnology company, announced today the successful completion of its Series A funding","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/founderlodge.com\/latest-news\/luminopia-secures-16-million-in-series-a-funding-to-advance-breakthrough-neuro-visual-disorder-treatments\/","og_locale":"en_US","og_type":"article","og_title":"Luminopia Secures $16 Million in Series A Funding","og_description":"Cambridge, Massachusetts \u2013 Luminopia, a leading biotechnology company, announced today the successful completion of its Series A funding","og_url":"https:\/\/founderlodge.com\/latest-news\/luminopia-secures-16-million-in-series-a-funding-to-advance-breakthrough-neuro-visual-disorder-treatments\/","og_site_name":"Founder Lodge Latest News","article_published_time":"2023-06-30T08:16:31+00:00","article_modified_time":"2023-06-30T08:16:32+00:00","og_image":[{"width":1601,"height":782,"url":"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/06\/image-345.png","type":"image\/png"}],"author":"ucheezuma","twitter_card":"summary_large_image","twitter_misc":{"Written by":"ucheezuma","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/founderlodge.com\/latest-news\/luminopia-secures-16-million-in-series-a-funding-to-advance-breakthrough-neuro-visual-disorder-treatments\/#article","isPartOf":{"@id":"https:\/\/founderlodge.com\/latest-news\/luminopia-secures-16-million-in-series-a-funding-to-advance-breakthrough-neuro-visual-disorder-treatments\/"},"author":{"name":"ucheezuma","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/2854d3c2f2bb3f7ff9ae13c649048af3"},"headline":"Luminopia Secures $16 Million in Series A Funding to Advance Breakthrough Neuro-Visual Disorder Treatments","datePublished":"2023-06-30T08:16:31+00:00","dateModified":"2023-06-30T08:16:32+00:00","mainEntityOfPage":{"@id":"https:\/\/founderlodge.com\/latest-news\/luminopia-secures-16-million-in-series-a-funding-to-advance-breakthrough-neuro-visual-disorder-treatments\/"},"wordCount":251,"commentCount":0,"publisher":{"@id":"https:\/\/founderlodge.com\/latest-news\/#organization"},"articleSection":["Daily Startup Funding News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/founderlodge.com\/latest-news\/luminopia-secures-16-million-in-series-a-funding-to-advance-breakthrough-neuro-visual-disorder-treatments\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/founderlodge.com\/latest-news\/luminopia-secures-16-million-in-series-a-funding-to-advance-breakthrough-neuro-visual-disorder-treatments\/","url":"https:\/\/founderlodge.com\/latest-news\/luminopia-secures-16-million-in-series-a-funding-to-advance-breakthrough-neuro-visual-disorder-treatments\/","name":"Luminopia Secures $16 Million in Series A Funding","isPartOf":{"@id":"https:\/\/founderlodge.com\/latest-news\/#website"},"datePublished":"2023-06-30T08:16:31+00:00","dateModified":"2023-06-30T08:16:32+00:00","description":"Cambridge, Massachusetts \u2013 Luminopia, a leading biotechnology company, announced today the successful completion of its Series A funding","breadcrumb":{"@id":"https:\/\/founderlodge.com\/latest-news\/luminopia-secures-16-million-in-series-a-funding-to-advance-breakthrough-neuro-visual-disorder-treatments\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/founderlodge.com\/latest-news\/luminopia-secures-16-million-in-series-a-funding-to-advance-breakthrough-neuro-visual-disorder-treatments\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/founderlodge.com\/latest-news\/luminopia-secures-16-million-in-series-a-funding-to-advance-breakthrough-neuro-visual-disorder-treatments\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/founderlodge.com\/latest-news\/"},{"@type":"ListItem","position":2,"name":"Luminopia Secures $16 Million in Series A Funding to Advance Breakthrough Neuro-Visual Disorder Treatments"}]},{"@type":"WebSite","@id":"https:\/\/founderlodge.com\/latest-news\/#website","url":"https:\/\/founderlodge.com\/latest-news\/","name":"Founder Lodge Latest News","description":"Get the latest updates on funding rounds and investment news for startups and businesses. Stay informed on capital raising trends and who&#039;s raising capital.","publisher":{"@id":"https:\/\/founderlodge.com\/latest-news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/founderlodge.com\/latest-news\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/founderlodge.com\/latest-news\/#organization","name":"Founder Lodge","url":"https:\/\/founderlodge.com\/latest-news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Founder Lodge"},"image":{"@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/2854d3c2f2bb3f7ff9ae13c649048af3","name":"ucheezuma","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ff09ab70d3a1229d484147623818e0af?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ff09ab70d3a1229d484147623818e0af?s=96&d=mm&r=g","caption":"ucheezuma"},"url":"https:\/\/founderlodge.com\/latest-news\/author\/ucheezuma\/"}]}},"_links":{"self":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/6600"}],"collection":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/comments?post=6600"}],"version-history":[{"count":1,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/6600\/revisions"}],"predecessor-version":[{"id":6605,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/6600\/revisions\/6605"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/media\/6604"}],"wp:attachment":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/media?parent=6600"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/categories?post=6600"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/tags?post=6600"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}